FR2275215A1 - Nouveaux derives heterocycliques de desacetoxycephalosporine, procede pour leur preparation et application en tant que medicament - Google Patents

Nouveaux derives heterocycliques de desacetoxycephalosporine, procede pour leur preparation et application en tant que medicament

Info

Publication number
FR2275215A1
FR2275215A1 FR7519213A FR7519213A FR2275215A1 FR 2275215 A1 FR2275215 A1 FR 2275215A1 FR 7519213 A FR7519213 A FR 7519213A FR 7519213 A FR7519213 A FR 7519213A FR 2275215 A1 FR2275215 A1 FR 2275215A1
Authority
FR
France
Prior art keywords
desacetoxycephalosporin
heterocyclical
derivatives
preparation
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7519213A
Other languages
English (en)
French (fr)
Other versions
FR2275215B1 (nl
Inventor
Marc Montavon
Roland Reiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2275215A1 publication Critical patent/FR2275215A1/fr
Application granted granted Critical
Publication of FR2275215B1 publication Critical patent/FR2275215B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56—One oxygen atom and one sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7519213A 1974-06-21 1975-06-19 Nouveaux derives heterocycliques de desacetoxycephalosporine, procede pour leur preparation et application en tant que medicament Granted FR2275215A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH853774A CH609989A5 (en) 1974-06-21 1974-06-21 Process for the preparation of acyl derivatives

Publications (2)

Publication Number Publication Date
FR2275215A1 true FR2275215A1 (fr) 1976-01-16
FR2275215B1 FR2275215B1 (nl) 1980-05-16

Family

ID=4341690

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7519213A Granted FR2275215A1 (fr) 1974-06-21 1975-06-19 Nouveaux derives heterocycliques de desacetoxycephalosporine, procede pour leur preparation et application en tant que medicament

Country Status (25)

Country Link
JP (1) JPS625917B2 (nl)
AT (1) AT337897B (nl)
AU (1) AU498387B2 (nl)
BE (1) BE830455A (nl)
BR (1) BR7503782A (nl)
CA (1) CA1111021A (nl)
CH (1) CH609989A5 (nl)
CU (1) CU34293A (nl)
DD (1) DD121113A5 (nl)
DE (1) DE2527291A1 (nl)
DK (2) DK153155C (nl)
FI (1) FI751815A (nl)
FR (1) FR2275215A1 (nl)
GB (1) GB1471804A (nl)
HU (1) HU170576B (nl)
IE (1) IE41888B1 (nl)
IL (1) IL47299A (nl)
LU (1) LU72771A1 (nl)
NL (1) NL180665C (nl)
NO (1) NO752202L (nl)
NZ (1) NZ177508A (nl)
PH (1) PH13030A (nl)
SE (1) SE431755B (nl)
SU (2) SU635873A3 (nl)
ZA (1) ZA753086B (nl)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000005A1 (de) * 1977-06-03 1978-12-20 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Neue Cephalosporinderivate, Verfahren zu ihrer Herstellung und pharmazeutische Präparate
FR2474030A1 (fr) * 1980-01-17 1981-07-24 Rhone Poulenc Ind Nouvelles dioxotriazines et leur preparation
EP0045525A2 (de) * 1978-05-30 1982-02-10 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Cephalosporinderivate und deren Herstellung
FR2494278A1 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouveaux derives de la cephalosporine, leurs preparations et les medicaments qui les contiennent

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5419990A (en) * 1977-07-14 1979-02-15 Shionogi & Co Ltd Dihydrotriazinylthioxacephalosporin
CN1531539A (zh) * 2001-04-19 2004-09-22 ��ŷ�����¶����ǹɷ����޹�˾ 用α-酮酸衍生物制备头孢烷酸衍生物的酶促方法
KR101637381B1 (ko) 2008-03-05 2016-07-07 메르크 파텐트 게엠베하 인슐린 분비 자극제들로서의 피라지논 유도체들, 이들을 얻기 위한 방법들 및 당뇨병 치료를 위한 이들의 용도

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868369A (en) * 1972-11-14 1975-02-25 Smithkline Corp 3-heterocyclicthiomethylcephalosporins

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000005A1 (de) * 1977-06-03 1978-12-20 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Neue Cephalosporinderivate, Verfahren zu ihrer Herstellung und pharmazeutische Präparate
EP0045525A2 (de) * 1978-05-30 1982-02-10 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Cephalosporinderivate und deren Herstellung
EP0045525A3 (en) * 1978-05-30 1982-02-17 F. Hoffmann-La Roche & Co. Aktiengesellschaft Cephalosporin derivatives and process for their preparation
FR2474030A1 (fr) * 1980-01-17 1981-07-24 Rhone Poulenc Ind Nouvelles dioxotriazines et leur preparation
FR2494278A1 (fr) * 1980-11-20 1982-05-21 Rhone Poulenc Ind Nouveaux derives de la cephalosporine, leurs preparations et les medicaments qui les contiennent
EP0053539A1 (fr) * 1980-11-20 1982-06-09 Rhone-Poulenc Sante Nouveaux dérivés de la céphalosporine, leur préparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
DK153155C (da) 1988-10-31
DD121113A5 (nl) 1976-07-12
ZA753086B (en) 1976-04-28
ATA476975A (de) 1976-11-15
SE431755B (sv) 1984-02-27
IE41888L (en) 1975-12-21
BR7503782A (pt) 1976-07-06
HU170576B (nl) 1977-07-28
JPS5113793A (nl) 1976-02-03
JPS625917B2 (nl) 1987-02-07
GB1471804A (en) 1977-04-27
IL47299A0 (en) 1976-10-31
CA1111021A (en) 1981-10-20
IL47299A (en) 1979-01-31
AU8191275A (en) 1976-12-09
DK153155B (da) 1988-06-20
NL180665C (nl) 1987-04-01
DK453687D0 (da) 1987-08-28
LU72771A1 (nl) 1977-03-04
SU635873A3 (ru) 1978-11-30
NO752202L (nl) 1975-12-23
IE41888B1 (en) 1980-04-23
CH609989A5 (en) 1979-03-30
SU589921A3 (ru) 1978-01-25
DK271975A (da) 1975-12-22
AT337897B (de) 1977-07-25
DK453687A (da) 1987-08-28
CU34293A (es) 1979-01-16
NL180665B (nl) 1986-11-03
DE2527291C2 (nl) 1988-01-14
NL7507390A (nl) 1975-12-23
NZ177508A (en) 1978-04-03
SE7506908L (sv) 1975-12-22
BE830455A (fr) 1975-12-22
DK155329C (da) 1989-08-07
DK155329B (da) 1989-03-28
DE2527291A1 (de) 1976-01-08
PH13030A (en) 1979-11-15
FI751815A (nl) 1975-12-22
FR2275215B1 (nl) 1980-05-16
AU498387B2 (en) 1979-03-08

Similar Documents

Publication Publication Date Title
BE846104A (fr) Nouveaux benzylates quaternaires de n-alcoyl-nortropines n-b-substituees, procede pour leur preparation et medicament en renfermant
BE833731A (fr) Derives d'alcool benzylique, procede pour leur preparation et application comme medicament
FR2282893A1 (fr) Derives de thienothiazine utiles en tant que medicaments et leur procede de preparation
FR2285864A1 (fr) Nouveaux derives polyeniques, leur procede de preparation et leur application en tant que medicaments
BE845581A (fr) Nouvelles oxazolidinones-(2), leur procede de preparation et leur application en tant que medicaments
FR2275215A1 (fr) Nouveaux derives heterocycliques de desacetoxycephalosporine, procede pour leur preparation et application en tant que medicament
FR2292467A1 (fr) Nouveaux derives de la benzophenone, leur procede de preparation et leur application comme medicament
FR2289187A1 (fr) Nouvelles 2-(5- ou 3-pyrazolyl)-benzophenones, leur procede de preparation et leur application en tant que medicament
FR2285870A1 (fr) Nouveaux derives de benzofurane, leur procede de preparation et leur application en tant que medicaments
BE833807A (fr) Phenoxyalkanecarbonamides d'acides thiazolidinecarboxyliques substitues, procede pour leur preparation et application comme medicament
FR2294708A1 (fr) Nouvelles 3-fluoro-2,3-dihydro-1h-1,4-benzodiazepine-2-ones, utiles en tant que medicaments et leur procede de preparation
BE845320A (fr) Nouveaux acides 7beta-(d-2-amino-2-(alcoyl inferieur-sulfonylamino-phenyl) -acetylamino) -3-r-3-cephem-4-carboxyliques, leur procede de preparation et leur application en tant que medicaments
FR2292472A1 (fr) Nouveaux derives d'isoindole utiles en tant que medicaments, et leur procede de preparation
BE831900A (fr) Nouveaux derives de piperidine utiles en tant que medicaments et procede pour leur preparation
FR2341584A1 (fr) Nouveaux derives de thienothiazine, leur procede de preparation et leur application en tant que medicaments
FR2315260A1 (fr) Nouveaux composes araliphatiques dihalogenes, leur application en tant que medicaments et leur procede de preparation
FR2351994A1 (fr) Composes 9-(5-o-acyl-b-d-arabinofuranosyl)-adeniniques, procede pour leur preparation et application en tant que medicaments
FR2291756A1 (fr) Nouveaux derives de quinoxaline-1,4-dioxyde, procede de preparation de ces derives et medicaments les contenant
FR2280377A1 (fr) Nouveaux derives de piperidine utiles en tant que medicaments et procede pour leur preparation
FR2285137A1 (fr) Nouveaux derives steroides 17-spirosultines, les g-hydroxyacides correspondants, leur procede de preparation et leur application comme medicament
BE811560A (fr) Derives du thiophene, leur procede de preparation et leur application comme medicament
FR2276040A1 (fr) Nouveaux derives de benzhydryloxy-alcoylamines, leur procede de preparation et medicaments contenant ces derives
FR2314709A1 (fr) Nouveaux derives alcyniques, leur procede de preparation et leur application en tant que medicaments
FR2330391A1 (fr) Nouveaux derives d'imidazole, leur application en tant que medicaments et leur procede de preparation
FR2287902A1 (fr) Nouveaux d-homosteroides, leur procede de preparation et leur application en tant que medicaments

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse